Notice ID: a03fd7a7498b484eab17aa95a684efaePresolicitationArchived
Notice of Intent to Sole Source – Stryker Sales, LLC - LIFEPAK 35 Defibrillators - High Configuration
Archived on August 13, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 12:00 PM EDT
- Posted
- July 30, 2026
- Notice type
- Presolicitation
- NAICS
- 334510: Electromedical and Electrotherapeutic Apparatus Manufacturing
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH OLAO
- Place of performance
- Bethesda, 20892
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- NOI-OD-26-007444
- Notice ID
- a03fd7a7498b484eab17aa95a684efae
Description
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. This procurement is for two LIFEPAK 35 Defibrillators - High Configuration. These defibrillators will support patient care in the Clinical Center PICU. Only Stryker can provide defibrillators, supplies and software that is compatible with the CC-Wide defibrillator supplies and attachments. The NIH Fire Department and Montgomery County primary response use the same Stryker Life-Pak 35 defibrillators and accessories that are compatible with the CC Stryker Life-Pak 35. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 –Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Ryssa Nix, Contract Specialist via email to Ryssa.nix@nih.gov by close date. Notice Type: Notice of Intent NAICS Code: 334510 PSC Code: 6515 Posted Date: 07/30/2026 Close Date: 08/13/2026 12pm EST End User IC: Clinical Center POC Name: Ryssa Nix
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Chris Ryssa Nix
Documents
Files (1)
- Download
NOI to sole source under SAT.docx
23 KBAdded in Presolicitation version 3Posted
Lifecycle
- 3Version 3PresolicitationArchivedCurrent
Notice of Intent to Sole Source – Stryker Sales, LLC - LIFEPAK 35 Defibrillators - High Configuration
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
The National Institutes of Health (NIH), National Institute of Child Health and Human Development (NICHD), intends to award a contract to BIO-RAD on a sole-source basis pursuant to FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements, for the acquisition of QX700 E Droplet Digital PCR System, the Government intends to solicit and award a Purchase Order on a solesource basis because the Government's minimum technical requirements will be satisfied by BIO-RAD. DTM’s shared labs have ongoing experiments that require very precise assessment of sample quality and quantity. The QX700 E Droplet Digital PCR System delivers the power of absolute quantification for our labs — without the need for standard curves. With simple setup, intuitive analysis, and 7-color multiplexing, it makes digital PCR more accessible than ever. All-in-one, integrated instrument enabling walkaway operation. Intuitive software with a user-friendly interface for easy run setup and data analysis. Generates absolute quantification results with intuitive software. A compact system built for low throughput or ad hoc studies and shared research spaces. Supports from 16, 32, or up to 48 samples per run, ensuring flexibility for low-throughput laboratories. The QX700 E Droplet Digital PCR System* delivers the power of absolute quantification for our labs — without the need for standard curves. With simple setup, intuitive analysis, and 7-color multiplexing, it makes digital PCR more accessible than ever. All-in-one, integrated instrument enabling walkaway operation. Intuitive software with a user-friendly interface for easy run setup and data analysis. Generates absolute quantification results with intuitive software. A compact system built for low throughput or ad hoc studies and shared research spaces. Supports from 16, 32, or up to 48 samples per run, ensuring flexibility for low-throughput laboratories. BioRad Laboratories, Inc. is the original manufacturer and sole supplier of the QX700 E Droplet Digital PCR System. This piece of equipment utilizes Droplet Digital PCR for the absolute quantification of nucleic acids. This notice is not a request for competitive quotations. However, interested parties that believe they can meet the Government's requirements may submit a capability statement demonstrating their ability to provide the required supplies and meet all specified technical and operational requirements. The Government will consider all timely capability statements received and determine whether the acquisition should proceed as a sole-source procurement or be competed. The Government anticipates making an award approximately five (5) calendar days after the closing date of this notice, unless the Government determines that another responsible source is capable of meeting the requirement. Capability statements shall be submitted electronically to davisroshonna@mail.nih.gov no later than 9:00 a.m. EDT on November 18, 2026. Please reference Notice No. 75N98027Q00057 in the subject line of the response. | 68% | Combined Synopsis | 11/18/2026 |
12 NOV 2026 - The purpose of this revision is to incorporate the additional questions from industry after the posting of Revision 1 of the RPP. The additional questions and answers are titled W91CRB-RPP-USHC_QAs_Rev1 12 NOV 2026. ***************************************************************************************************************************************************** 4 NOV 2026 - The purpose of this revision is to incorporate Revision 1 of the RPP, upload the Questions and Answers and to extend the offeror due date to 1600 EST, 20 November 2026. With the incorporation of this revision, final questions are due NLT 1600 EST, 9 November 2026. A follow on Questions and Answers for this period will be uploaded shortly after 9 November 2026. Three attachments will be uploaded in this RPP revision: 1) W91CRB-RPP-USHC_Rev 1 - changes are highlighted in red font to the following sections of the RPP: Sections 2.4, 5.1 & 5.2 2) W91CRB-RPP-USHC_QAs - .pdf containing 10 questions and answers 3) W91CRB-RPP-USHC_QAs_Cont. - Excel spreadsheet containing remaining questions ****************************************************************************************************************************************************** The Portfolio Acquisition Executive (PAE) Maneuver Ground Project Manager (PM) Maneuver Medical Devices (M2S) is issuing this Request for Prototype Proposals (RPP) to solicit solutions for an Ultrasound Diagnostic System, Hand Carried (USHC). The U.S. Army requires a Commercial-Off-The-Shelf (COTS) or Non-Developmental Item (NDI) hand-carried ultrasound device capable of supporting medical operations in austere Role of Care (ROC) 3 environments with little to no modification. The selected vendor(s) will deliver two (2) prototype units for operational and environmental testing (MIL-STD-810H). The solution must be FDA cleared for human use, Trade Agreements Act (TAA) compliant, and operate on standard CONUS/OCONUS power infrastructures. In accordance with 10 U.S.C. § 4022(f), the Government advises all offerors that a noncompetitive follow-on production contract or transaction may be awarded to the participant(s) of this Prototype Other Transaction Agreement (OTA) without the use of competitive procedures Submission Instructions: Proposals must be submitted via DoD SAFE file transfer or secure email. Submit to: Timothy Compton, Agreements Officer (timothy.j.compton7.civ@army.mil) Copy to: Roxanne A. Dalrymple, Agreements Specialist (roxanne.a.dalrymple.civ@army.mil) Please see attached. | 64% | Solicitation | 11/20/2026 |
Portfolio Acquisition Executive (PAE) Maneuver Ground Project Manager (PM) Maneuver Medical Devices (M2S) is issuing this Request for Prototype Proposals (RPP) under Other Transaction Authority (OTA) pursuant to 10 U.S.C. § 4022 to solicit prototype project proposals for a Scanner Ultrasonic Ocular device. The purpose of this RPP is to identify, select, and award two (2) prototype Other Transaction (OT) Agreement —for the delivery and demonstration of prototype scanner ultrasonic ocular devices that address the capability gap described herein. The awardee(s) shall deliver four (4) prototype devices for operational and environmental testing. The goal is to procure an FDA-approved commercial solution that requires minimal to no modifications to meet the technical specifications identified herein. | 64% | Combined Synopsis | 11/12/2026 |
NX EQ Image Guided Surgical Navigation System | 64% | Market Research | 09/18/2026 |
Notice Number: REQT-IHS-2026-00220 SOURCES SOUGHT NOTICE This is a Sources Sought Notice Announcement only. This advertisement is not a solicitation for offers, nor is it a request for quotes. A request for quotes may be issued at a later date. Portland Area Indian Health Service (PAIHS) seeks vendors to deliver five (5) new, complete all-in-one Vital Signs Monitoring and Physical Assessment Units to Chemawa Indian Health Center, Western Oregon Service Unit (WOSU), Salem, Oregon. Each unit must support noninvasive blood pressure, pulse rate, temperature, oxygen saturation (SpO2), noninvasive hemoglobin/total hemoglobin measurement, otoscopy, and ophthalmoscopy. Include compatible adult and pediatric accessories, sensors, probes, cables, power supplies, manuals, warranty, cleaning/disinfection, and maintenance documentation. Units must operate independently; no electronic medical record/RPMS integration or on-site services are included. The purpose of this notice is to obtain: (1) availability and capability of Indian-owned businesses, other small businesses, and large businesses; (2) socioeconomic status, including HUBZone, service-disabled veteran-owned, veteran-owned, 8(a), women-owned, and small disadvantaged businesses; and (3) size classification under anticipated North American Industry Classification System (NAICS) code 334510, Electromedical and Electrotherapeutic Apparatus Manufacturing. The small business size standard is 1,250 employees. Responses will inform the acquisition method and potential set-aside, including consideration of Indian Small Business Economic Enterprises (ISBEE) and Indian Economic Enterprises (IEE) under 25 U.S.C. 47, the Buy Indian Act. Interested parties shall not be reimbursed for costs associated with preparation of their responses. Any proprietary information should be marked. Interested organizations presenting a capability statement in response to this Sources Sought Notice must identify their size status. Respondents must be registered in the System for Award Management (SAM) at https://sam.gov and maintain current representations and certifications in SAM. Responses should include: Business name. Point of contact, phone number, and email address. Unique Entity ID (UEI). Business size: small or large. Business type, including ISBEE/IEE and other socioeconomic status. Capability and capacity to deliver all five units, manufacturer/model, product literature addressing required capabilities, accessory configuration, warranty information, and delivery lead time. Identify whether your firm is a manufacturer or distributor/reseller. Submit capability statements in MS Word or Adobe Portable Document Format (PDF) to PORAOAcquisition@ihs.gov, with “REQT-IHS-2026-00220” in the subject line. Responses are due November 25, 2026, at 5:00 PM Pacific Time. Contracting Office Address Portland Area Office Attention: Jacob Blalock, Purchasing Agent 1414 NW Northrup Street, Suite 800 Portland, OR 97209 Email: PORAOAcquisition@ihs.gov Place of Delivery/Performance Western Oregon Service Unit 3750 Chemawa Road NE Salem, OR 97305 | 61% | Market Research | 11/25/2026 |
Additional Details
Solicitation Number
NOI-OD-26-007444
Archive Date
Aug 13, 2026
Office Address
BETHESDA, MD, 20892